1. Home
  2. PAVM vs VRAX Comparison

PAVM vs VRAX Comparison

Compare PAVM & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAVM
  • VRAX
  • Stock Information
  • Founded
  • PAVM 2014
  • VRAX 2013
  • Country
  • PAVM United States
  • VRAX United Kingdom
  • Employees
  • PAVM N/A
  • VRAX N/A
  • Industry
  • PAVM Medical/Dental Instruments
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PAVM Health Care
  • VRAX Health Care
  • Exchange
  • PAVM Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • PAVM 12.0M
  • VRAX 4.7M
  • IPO Year
  • PAVM 2016
  • VRAX 2022
  • Fundamental
  • Price
  • PAVM $0.60
  • VRAX $0.85
  • Analyst Decision
  • PAVM Strong Buy
  • VRAX Strong Buy
  • Analyst Count
  • PAVM 1
  • VRAX 1
  • Target Price
  • PAVM $19.00
  • VRAX $3.00
  • AVG Volume (30 Days)
  • PAVM 149.7K
  • VRAX 37.2K
  • Earning Date
  • PAVM 08-11-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • PAVM N/A
  • VRAX N/A
  • EPS Growth
  • PAVM N/A
  • VRAX N/A
  • EPS
  • PAVM 0.96
  • VRAX N/A
  • Revenue
  • PAVM $1,993,000.00
  • VRAX $6,331.00
  • Revenue This Year
  • PAVM N/A
  • VRAX $5,169.18
  • Revenue Next Year
  • PAVM $455.63
  • VRAX $66.97
  • P/E Ratio
  • PAVM $0.62
  • VRAX N/A
  • Revenue Growth
  • PAVM N/A
  • VRAX N/A
  • 52 Week Low
  • PAVM $0.55
  • VRAX $0.74
  • 52 Week High
  • PAVM $1.90
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • PAVM 42.72
  • VRAX 45.02
  • Support Level
  • PAVM $0.57
  • VRAX $0.74
  • Resistance Level
  • PAVM $0.62
  • VRAX $0.88
  • Average True Range (ATR)
  • PAVM 0.04
  • VRAX 0.07
  • MACD
  • PAVM -0.00
  • VRAX 0.01
  • Stochastic Oscillator
  • PAVM 23.46
  • VRAX 50.23

About PAVM PAVmed Inc.

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: